Masoud H. Manjili - Concepedia

Author

Masoud H. Manjili

Also Known As

Abdullah A. Toor, Angelo A. Manfredi, M MANJILI, M. H. Manjili, M. Manjili, M.H Manjili, M.H. Manjili, Manjili, Masoud H., Masoud H. Manjili, Masoud H Manjili

232

Publications

Citations

H-Index

Concepts

All Affiliations

Virginia Commonwealth University Roswell Park Comprehensive Cancer Center VCU Massey Comprehensive Cancer Center Virginia Cancer Institute Mayo Clinic

About

Masoud H. Manjili is an author at Virginia Commonwealth University specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	33	2.7K
2	Cell Biology	20	23	2.1K
3	Health Sciences	3	3	659
4	Cellular Therapies	3	3	159
5	Allergy	2	2	106

Masoud H. Manjili

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells Marta Santisteban, Jennifer M. Reiman, Michael K. Asiedu, Cancer Research Breast OncologyAdult Stem CellImmunologyTumor BiologyEpithelial-mesenchymal Transition	2009	378
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice Hanh K. Le, Laura Graham, Esther Cha, International Immunopharmacology T CellsImmunologyImmune Checkpoint InhibitorTumor SuppressorBalb/c Mice	2009	362
CD44+/CD24−/low cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome Michael O. Idowu, Maciej Kmieciak, Catherine I. Dumur, Human Pathology Breast OncologyPoor OutcomeMedicineStem CellsCancer Cell Biology	2011	270
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells Johanna K. Morales, Maciej Kmieciak, Keith L. Knutson, Breast Cancer Research and Treatment Tumor BiologyBreast OncologyMedicineImmunologyMyeloid-derived Suppressor Cells	2009	214
A signature of immune function genes associated with recurrence-free survival in breast cancer patients Maria Libera Ascierto, Maciej Kmieciak, Michael O. Idowu, Breast Cancer Research and Treatment Breast OncologyCancer ImmunosurveillanceBreast Cancer PatientsRecurrence-free SurvivalImmunology	2011	171
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function Maciej Kmieciak, Madhu Gowda, Laura Graham, Journal of Translational Medicine	2009	166
HSP110-HER2/ <i>neu</i> Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/ <i>neu</i> Transgenic Mice Masoud H. Manjili, Xiangyang Wang, Xing Chen, The Journal of Immunology	2003	109
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients Maria Libera Ascierto, Michael O. Idowu, Yingdong Zhao, Journal of Translational Medicine	2013	103
HER‐2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell‐mediated anti‐tumor immune responses Maciej Kmieciak, Keith L. Knutson, Catherine I. Dumur, European Journal of Immunology ImmunologyImmune RegulationTumor EscapeImmunoeditingAntigen Processing	2007	100
Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity Sheinei Saleem, Rebecca Martin, Johanna K. Morales, The Journal of Immunology Mast Cell DisorderInnate Immune SystemImmunologyImmunologic MechanismInnate Immunity	2012	92

Page 1